View More

Expansion of Arthroplasty Surgery Robot 'CUVIS-joint' into Myanmar

CUREXO's artificial joint surgery robot, 'CUVIS-joint', has obtained local regulatory approval from the Department of Food and Drug Administration (FDA) of Myanmar.CUREXO's partner in Myanmar is Zeya & Associates Co., Ltd., an EPC and engineering company specializing in the energy (power), medical, and industrial sectors.Based on this Myanmar approval, CUREXO plans to expand its entry into emerging countries by taking the lead in the Southeast Asian medical robot market.

View More

40th Annual Meeting of NASS in Denver

CUREXO participated in the 40th Annual Meeting of the North American Spine Society (NASS) held in Denver, USA, from November 14 to 16. At the exhibition, CUREXO, in collaboration with CGBio, showcased its spinal surgery robot CUVIS-Spine and spinal navigation system to local medical professionals and global partners. CUREXO plans to continue strengthening its foundation for expanding its presence in the spinal surgery robotics field and further develop partnerships across North America.

View More

CUVIS-joint in Japan

The first installation of Cuvis-joint in Japan has been completed at Tachibana Hospital, where the initial surgery using CUVIS-joint was successfully performed today, led by Dr. Kashiwagi.Our sincere thanks go to Tachibana Hospital, Dr. Kashiwagi, our valued partner Kyocera Medical Corporation, and the dedicated CUREXO team for their collaboration and efforts.This achievement marks an important step in expanding the global presence of CUVIS-joint and advancing precision and safety in orthopedic surgery through innovative robotic technology.

View More

KARM 2025

The 53rd Annual Meeting and International Conference of The Korean Academy of Rehabilitation Medicine(KARM 2025) was held from October 24(Fri) to 25(Sat) at the Grand Hyatt Incheon.CUREXO Inc. showcased its rehabilitation robot MorningWalk and engaged in consultations with various professionals in the field.In particular, MorningWalk users showed great interest in the newly introduced Propulsion Force Feedback System(PFF System), experiencing the system firsthand and sharing active feedback during the event.MorningWalk's PFF System ㅡis an optimized solution for intensive propulsion force training in gait rehabilitation ✔️ Advanced Robotic 3DoF arms continuously measure and train propulsive force ✔️ Unique foot plate joints offer exceptionally high freedom ✔️ Non-constraining saddle design ✔️ Timing-focused, feedback-driven VR module

View More

KOA 2025

CUREXO Inc. participated in the 69th Annual Congress of the Korean Orthopaedic Association (KOA 2025), held at COEX Magok from October 16 (Thu) to 18 (Sat), 2025. During the congress, CUREXO showcased the CUVIS-joint (THA), which recently received approval from the Ministry of Food and Drug Safety (MFDS), and had meaningful interactions with domestic and international medical professionals and stakeholders. CUVIS-joint (THA) is currently in the process of obtaining U.S. FDA and European CE certifications, as CUREXO continues to pursue global market expansion.

View More

AIRIS 2025 (AI Regulatory & International Symposium)

CUREXO, a leading medical robotics company, showcased its CUVIS-joint, an advanced joint replacement surgical robot, at AIRIS 2025 (AI Regulatory & International Symposium) held in September 2025.AIRIS 2025, co-hosted with the World Health Organization (WHO), brings together global regulatory authorities, industry leaders, and academic experts to discuss the latest technological trends and innovative cases in AI-based medical products. The symposium also features presentations from regulatory officials sharing their experiences in approval processes and providing insights into the future of AI regulation.- Event Name: AIRIS 2025 (AI Regulatory & International Symposium)- Theme: Regulation for AI, Together for Tomorrow- Hosts: Ministry of Food and Drug Safety (MFDS), WHO- Date: September 10 (Wed) – 12 (Fri), 2025- Venue: Inspire Resort, Incheon, Korea

View More

Curexo Presents Morning Walk Research Findings at AOCPRM

From August 21 to 23, Curexo participated in the 9th Asia Oceanian Conference of Physical and Rehabilitation Medicine (AOCPRM) held in Malaysia, where it presented research findings on its gait rehabilitation robot, Morning Walk.   The presentation highlighted that training using Morning Walk's Propulsion Force Feedback (PFF) system was effective in improving patients' gait propulsion, and that joint movement patterns observed during gait training with Morning Walk were similar to those of actual overground walking. This presentation served as an opportunity to demonstrate the clinical value of Morning Walk on an international stage, and Curexo will continue to strengthen its presence in the global rehabilitation robot market.

View More

Morning Walk User Meeting 2025

From Saturday, July 5 to Sunday, July 6, CUREXO successfully hosted the MorningWalk User Meeting 2025 at SONO BELLE Cheonan, joined by approximately 100 therapists and professors who currently use MorningWalkUnder the theme "Re-Discovery & Future Chapters,"the meeting featured presentations on:- the latest research based on the ded features of MorningWalk- New programs currently under development, derived from existing functionalitiesThe event served as a valuable platform for sharing clinical knowledge and experience, aimed at providing safer and more effective gait rehabilitation training for patients. We sincerely thank all the therapists and professors who delivered presentations despite their busy schedules.Having progressed through the MW 1.5 and MW-S200 models, MorningWalk is set to launch the new MW-S200C model in 2025, further enhancing its capacity to provide personalized gait rehabilitation tailored to various age groups and clinical needs.CUREXO remains committed to supporting faster recovery for patients experiencing gait difficultiesand improving ease of use for therapists through continuous innovation.Thank you.

View More

Approval from DINAVISA, Dirección Nacional de Vigilancia Sanitaria Paraguay

CUREXO's artificial joint surgery robot, CUVIS-joint, has received local regulatory approval from DINAVISA, Dirección Nacional de Vigilancia Sanitaria Paraguay. CUREXO's partner in Paraguay is DROGUEPAR S.A, a distributor of pharmaceuticals and medical devices, and this approval is expected to serve as a bridgehead for expanding into the Latin American market.